Antimicrobial activity of dalbavancin tested against Gram-positive organisms isolated from patients with infective endocarditis in US and European medical centres Free

• Abstract
• Supplementary data

Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015–16 Free

• Abstract

Antimicrobial activity of oritavancin and comparator agents when tested against Gram-positive bacterial isolates causing infections in cancer patients (2014–16) Free

• Abstract

ZAAPS Program results for 2015: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 32 countries Free

• Abstract

Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012–15) Free

• Abstract

Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates Open Access

• Abstract

Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST) Get access

• Abstract

Pre-clinical development of antifungal susceptibility test methods for the testing of the novel antifungal agent E1210 versus Candida: comparison of CLSI and European Committee on Antimicrobial Susceptibility Testing methods Get access

• Abstract

Telavancin activity against Gram-positive bacteria isolated from respiratory tract specimens of patients with nosocomial pneumonia Get access

• Abstract

BMS284756 (formerly T-3811, a des-fluoroquinolone) potency and spectrum tested against over 10 000 bacterial bloodstream infection isolates from the SENTRY antimicrobial surveillance programme (2000) Get access

• Abstract

MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: resistance implications in the treatment of serious infections Get access

• Abstract

Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY Antimicrobial Surveillance Program (1998) Get access

• Abstract

Antibacterial activity of PD 131628 and proposed disc diffusion susceptibility test criteria Get access

• Abstract

Dirithromycin disc susceptibility tests: interpretative criteria and quality control parameters Get access

• Abstract

In-vitro susceptibility of nosocomial Gram-negative bloodstream pathogens to quinolones and other antibiotics—a statistical approach Get access

• Abstract

In-vitro activity of paldlmycin against methicillin-resistant and susceptible isolates of Staphylococcus aureus and S. epidermidis Get access